C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) C07K 14/045 (2006.01) C07K 14/16 (2006.01) C07K 14/54 (2006.01) C12N 5/10 (2006.01) C12N 15/12 (2006.01) C12N 15/26 (2006.01) C12P 21/00 (2006.01)
Patent
CA 2420771
A mammalian cell gene expression vector system comprising (a) an episomal maintenance system (b), a strong promoter/enhancer, (c) a protein transactivation system and (d) DNA coding for a heterologous protein. The episomal maintenance and protein transactivation systems can include sub- elements located on the same or different plasmids within the cell expression system.
L'invention concerne un système de vecteur d'expression génique de cellule mammalienne comprenant (a) un système de maintenance épisomique (b), un promoteur/activateur puissant, (c) un système de transactivation de protéine et (d) de l'ADN codant une protéine hétérologue. Les systèmes (a) et (c) peuvent comprendre des éléments secondaires situés sur des plasmides identiques ou différents dans le système d'expression cellulaire.
Cho Myung-Sam
Yee Helena
Bayer Pharmaceuticals Corporation
Borden Ladner Gervais Llp
Corporation Bayer
LandOfFree
Enhanced transfection system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced transfection system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced transfection system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1839601